AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Hernandez, JM Martin, G Gutierrez, NC Cervera, J Ferro, MT Calasanz, MJ Martinez-Climent, JA Luno, E Tormo, M Rayon, C Diaz-Mediavilla, J Gonzalez, M Gonzalez-San Miguel, JD Perez-Equiza, K Rivas, C Esteve, J Alvarez, MD Odriozola, J Ribera, JM Sanz, MA
Citation: Jm. Hernandez et al., Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA, HAEMATOLOG, 86(8), 2001, pp. 807-813

Authors: Urbano-Ispizua, A Brunet, S Solano, C Moraleda, JM Rovira, M Zuazu, J de la Rubia, J Bargay, J Caballero, D Diez-Martin, JL Ojeda, E de Oteiza, JP Ferra, C Espigado, I Alegre, A de la Serna, J Torres, P Riu, C Odriozola, J Rozman, C Sierra, J Garcia-Conde, J Montserrat, E
Citation: A. Urbano-ispizua et al., Allogeneic transplantation of CD34(+)-selected cells from peripheral bloodin patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation, BONE MAR TR, 28(4), 2001, pp. 349-354

Authors: Villalon, L Avello, AG Cesar, J Odriozola, J Lopez, J Oteyza, JP Larana, JG Cantalapiedra, A Navarro, JL
Citation: L. Villalon et al., Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?, THROMB RES, 99(5), 2000, pp. 439-446

Authors: Wiestner, A Padosch, SA Ghilardi, N Cesar, JM Odriozola, J Shapiro, A Skoda, RC
Citation: A. Wiestner et al., Hereditary thrombocythaemia is a genetically heterogenous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia, BR J HAEM, 110(1), 2000, pp. 104-109

Authors: Steegmann, JL Odriozola, J Rodriguez-Salvanes, F Giraldo, P Garcia-Larana, J Ferro, MT Benitez, E Perez-Pons, C Giralt, M Escribano, L Lavilla, E Miguel, A Areal, C Perez-Encinas, M Abad, A Maldonado, J Massague, I Fernandez-Ranada, JM
Citation: Jl. Steegmann et al., Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha 2a and CML, HAEMATOLOG, 84(11), 1999, pp. 978-987

Authors: Parra, C Roldan, E Rodriguez, C de Oteyza, JP Oteho, E Lopez, J Maldonado, MS Larana, JG Munoz, A Odriozola, J Brieva, JA
Citation: C. Parra et al., Reconstitution of peripheral blood lymphocytes in patients submitted to bone marrow transplantation: comparison between allogeneic and autologous, MED CLIN, 113(1), 1999, pp. 1-5

Authors: Facon, T Harousseau, JL Maloisel, F Attal, M Odriozola, J Alegre, A Schroyens, W Hulin, C Schots, R Marin, P Guilhot, F Granena, A De Waele, M Pigneux, A Meresse, V Clark, P Reiffers, J
Citation: T. Facon et al., Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirementsin multiple myeloma patients: A randomized, controlled trial, BLOOD, 94(4), 1999, pp. 1218-1225

Authors: Perez-Oteyza, J Bornstein, R Corral, M Hermosa, V Alegre, A Torrabadella, M Ramos, P Garcia, J Odriozola, J Navarro, JL
Citation: J. Perez-oteyza et al., Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study, HAEMATOLOG, 83(11), 1998, pp. 1001-1005
Risultati: 1-8 |